The WACC of Cerevel Therapeutics Holdings Inc (CERE) is 8.8%.
| Range | Selected | |
| Cost of equity | 7.70% - 10.20% | 8.95% |
| Tax rate | -% - -% | -% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.6% - 10.0% | 8.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.83 | 0.96 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.70% | 10.20% |
| Tax rate | -% | -% |
| Debt/Equity ratio | 0.04 | 0.04 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.6% | 10.0% |
| Selected WACC | 8.8% | |